Summary
The Dual Antiplatelet Therapy [DAPT] trial recruited patients from 5 studies conducted at 452 sites in 11 countries. The objective was to assess the efficacy and safety of dual antiplatelet therapy (DAPT) between 12 and 30 months in patients treated with coronary stents. This article discusses the primary results of the DAPT trial in the cohort treated with drug-eluting stents.
- interventional techniques & devices
- coronary artery disease
- cardiology clinical trials
- © 2014 MD Conference Express®
Tools
Table of contents
Cited By...
- No citing articles found.